{"id":"NCT03497975","sponsor":"Trevi Therapeutics","briefTitle":"PRISM Study-Pruritus Relief Through Itch Scratch Modulation","officialTitle":"A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study in Prurigo Nodularis (PN) With Nalbuphine ER Tablets for Pruritus Relief Through Itch Scratch Modulation (PRISM Study)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2018-08-07","primaryCompletion":"2022-05-10","completion":"2023-02-24","firstPosted":"2018-04-13","resultsPosted":"2025-06-24","lastUpdate":"2025-06-24"},"enrollment":353,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Prurigo Nodularis"],"interventions":[{"type":"DRUG","name":"Nalbuphine ER Tablets","otherNames":["NAL ER Tablets"]},{"type":"DRUG","name":"Placebo Tablets","otherNames":[]}],"arms":[{"label":"NAL ER","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To investigate the anti-pruritic efficacy and safety of Nalbuphine Extended Release (ER) (NAL ER) tablets in Prurigo Nodularis. Participants were randomized to NAL ER (or matching placebo) with the primary endpoint evaluation at Week 14. During the open label extension, participants who received NAL ER were continued on NAL ER and participants who received placebo would then shift to NALER.","primaryOutcome":{"measure":"Percentage of Participants With â‰¥ 4- Point Decrease in 7-day Average Worst Itch - Numerical Rating Scale (WI-NRS) up to Week 14","timeFrame":"Baseline up to Week 14","effectByArm":[{"arm":"NAL ER","deltaMin":24.24,"sd":null},{"arm":"Placebo","deltaMin":14.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0309"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":7},"locations":{"siteCount":70,"countries":["United States","Austria","France","Germany","Poland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":168},"commonTop":["Nausea","Dizziness","Headache","Fatigue","Somnolence"]}}